II
REGN icon

IFM Investors’s Regeneron Pharmaceuticals REGN Stock Holding History

IFM Investors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
24,134
+3,102
+15% +$2.11M 0.1% 190
2026
Q1 		$16.3M Buy
21,032
+294
+1% +$225K 0.14% 143
2025
Q4 		$16M Buy
20,738
+75
+0.4% +$50.9K 0.13% 130
2025
Q3 		$11.7M Sell
20,663
-634
-3% -$358K 0.1% 178
2025
Q2 		$11.2M Buy
21,297
+49
+0.2% +$27.3K 0.11% 181
2025
Q1 		$13.5M Sell
21,248
-102
-0.5% -$70.2K 0.15% 134
2024
Q4 		$15.2M Sell
21,350
-1,935
-8% -$1.62M 0.15% 118
2024
Q3 		$24.5M Buy
23,285
+27
+0.1% +$30K 0.23% 79
2024
Q2 		$24.4M Buy
23,258
+690
+3% +$669K 0.25% 78
2024
Q1 		$21.7M Sell
22,568
-134
-0.6% -$127K 0.24% 82
2023
Q4 		$19.9M Sell
22,702
-58
-0.3% -$47.8K 0.24% 84
2023
Q3 		$18.7M Buy
22,760
+1,859
+9% +$1.46M 0.25% 80
2023
Q2 		$15M Buy
20,901
+1,045
+5% +$806K 0.2% 97
2023
Q1 		$16.3M Buy
19,856
+466
+2% +$351K 0.25% 84
2022
Q4 		$14M Buy
19,390
+501
+3% +$370K 0.23% 94
2022
Q3 		$13M Buy
18,889
+376
+2% +$237K 0.24% 84
2022
Q2 		$10.9M Buy
18,513
+1,104
+6% +$718K 0.19% 107
2022
Q1 		$12.2M Buy
17,409
+3,659
+27% +$2.31M 0.19% 102
2021
Q4 		$8.68M Sell
13,750
-66
-0.5% -$40.6K 0.16% 123
2021
Q3 		$8.36M Sell
13,816
-35
-0.3% -$21.7K 0.17% 114
2021
Q2 		$7.74M Buy
13,851
+2,308
+20% +$1.17M 0.16% 132
2021
Q1 		$5.46M Buy
11,543
+1,523
+15% +$742K 0.15% 139
2020
Q4 		$4.84M Buy
10,020
+1,739
+21% +$939K 0.15% 132
2020
Q3 		$4.64M Buy
8,281
+1,132
+16% +$686K 0.19% 106
2020
Q2 		$4.46M Sell
7,149
-1,106
-13% -$628K 0.23% 90
2020
Q1 		$3.9M Buy
8,255
+249
+3% +$103K 0.17% 130
2019
Q4 		$3.01M Sell
8,006
-343
-4% -$115K 0.11% 197
2019
Q3 		$2.32M Buy
8,349
+2,415
+41% +$715K 0.09% 249
2019
Q2 		$1.86M Buy
5,934
+588
+11% +$196K 0.11% 209
2019
Q1 		$2.19M Buy
5,346
+765
+17% +$315K 0.14% 161
2018
Q4 		$1.71M Buy
4,581
+426
+10% +$156K 0.14% 160
2018
Q3 		$1.68M Buy
4,155
+588
+16% +$224K 0.13% 172
2018
Q2 		$1.23M Buy
3,567
+1,115
+45% +$349K 0.12% 186
2018
Q1 		$844K Buy
2,452
+262
+12% +$91.1K 0.12% 185
2017
Q4 		$823K Hold
2,190
– – 0.13% 175
2017
Q3 		$979K Buy
2,190
+45
+2% +$21.4K 0.17% 142
2017
Q2 		$1.05M Buy
2,145
+517
+32% +$226K 0.19% 124
2017
Q1 		$631K Buy
1,628
+611
+60% +$226K 0.16% 150
2016
Q4 		$373K Buy
+1,017
New +$387K 0.18% 151

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

IFM Investors's REGN Position: Q2 2026 in Review

IFM Investors increased its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, buying an estimated $2.11M and bringing the position to 24,134 shares worth $15M. The position accounts for 0.1% of the portfolio, ranked #190.

IFM Investors first reported a position in REGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $24.5M in Q3 2024. 311 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • IFM Investors held 24,134 shares of Regeneron Pharmaceuticals worth $15M as of Q2 2026.
  • IFM Investors bought 3,102 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.11M.
  • Regeneron Pharmaceuticals made up 0.1% of IFM Investors's portfolio in Q2 2026, its #190 holding.
  • IFM Investors first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Regeneron Pharmaceuticals position peaked at $24.5M in Q3 2024.
  • 311 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.